10-K Decoder · All companies

Amneal Pharmaceuticals, Inc.

AMRX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$3.02B$2.79B+8.0%
Operating income$394M$249M+58.1%
Net income$72.1M−$117M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$863M$784M+10.0%
Operating income$95.4M$70.3M+35.7%
Net income−$21.7M$2.40M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Amneal's revenue in FY2025?
$3.02B in FY2025 (Fiscal year ended Dec 31, 2025), +8.0% vs $2.79B a year earlier, per its 10-K filed Feb 2026.
Was Amneal profitable in FY2025?
Yes: net income was $72.1M and operating income $394M in FY2025.
What was Amneal's revenue in Q3 2026?
$863M (+10.0% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.